Abstract
The lower levels of serum uric acid (UA) correlated with meningitis have been reported. However, comparison of UA levels among different kinds of infections of central nervous system (CNS) and changes of UA levels before and after treatment are unknown. Our study aimed to investigate the antioxidant status of serum UA in five common types of CNS infections. We retrospectively evaluated serum UA levels of 399 patients with different types of CNS infections including viral meningitis or meningoencephalitis (VM), brain cysticercosis (BC), tuberculous meningitis or meningoencephalitis (TM), cryptococcus meningitis or meningoencephalitis (CM) and bacterial meningitis or meningoencephalitis (BM), and 119 healthy controls. The changes of serum UA were examined and analyzed. The serum levels of UA in patients with CNS infections were significantly lower than those in normal subjects and among in TM, CM and BM groups were apparently lower when compared with VM and BC groups; otherwise, after effective therapy, serum UA levels were obviously higher than before. Our findings showed that patients with CNS infections had lower serum UA levels, which was independent of the classification and the serum UA levels increased obviously after valid treatment, the variation of UA levels might be considered as an indicator of clinical curative effect in patients with CNS infections.
Similar content being viewed by others
References
Riddell J 4th, Shuman EK (2012) Epidemiology of central nervous system infection. Neuroimaging Clin N Am 22:543–556
Chong HT, Tan CT (2005) Epidemiology of central nervous system infections in Asia, recent trends. Neurol Asia 10:7–11
Leib SL, Täuber MG (1999) Pathogenesis of bacterial meningitis. Infect Dis Clin North Am 13:527–548
Leib SL, Kim YS, Chow LL, Sheldon RA, Täuber MG (1996) Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J Clin Invest 98:2632–2639
Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, Spitsin SV (2000) Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J 14:691–698
Hooper DC, Kean RB, Scott GS, Spitsin SV, Mikheeva T, Morimoto K, Bette M, Röhrenbeck AM, Dietzschold B, Weihe E (2001) The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J Immunol 167:3470–3477
Klein M, Koedel U, Pfister HW (2006) Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy? Prog Neurobiol 80:269–280
Liu Y, Jiang Y, Wu A, Chen S, Zhang Y, Liu M, Ma X, Ma L, Chen X (2012) Prognostic significance of serum antioxidant parameters in immunocompetent patients with cryptococcal meningitis. Eur J Clin Microbiol Infect Dis 31:2359–2367
Kurien BT, Scofield RH (2008) Autoimmunity and oxidatively modified. Autoimmun Rev 7:567–573
Toncev G, Milicic B, Toncev S, Samardzic G (2002) Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood–brain barrier dysfunction. Eur J Neurol 9:221–226
Peng F, Yang Y, Liu J, Jiang Y, Zhu C, Deng X, Hu X, Chen X, Zhong X (2012) Low antioxidant status of serum uric acid, bilirubin and albumin in patients with neuromyelitis optica. Eur J Neurol 19:277–283
Jesús S, Pérez I, Cáceres-Redondo MT, Carrillo F, Carballo M, Gómez-Garre P, Mir P (2013) Low serum uric acid concentration in Parkinson’s disease in southern Spain. Eur J Neurol 20:208–210
Bahr NC, Boulware DR (2014) Methods of rapid diagnosis for the etiology of meningitis in adults. Biomarkers Med 8:1085–1103
Garcia HH, Nash TE, Del Brutto OH (2014) Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 13:1202–1215
Aycicek A, Iscan A, Erel O, Akcali M, Ocak AR (2007) Oxidant and antioxidant parameters in the treatment of meningitis. Pediatr Neurol 37:117–120
Gutteridge JM, Halliwell B (2000) Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 899:136–147
Bonnefoy M, Drai J, Kostka T (2002) Antioxidants to slow aging, facts and perspectives. Presse Med 31:1174–1184
Tsukahara H (2002) Oxidative and nitrosative stress in childhood meningitis. Infect Immun Child 14:31–39
Tsukahara H, Haruta T, Hata I, Mayumi M (1998) Nitric oxide in septic and aseptic meningitis in children. Scand J Clin Lab Invest 58:73–79
Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:1424–1437
Kastenbauer S, Koedel U, Becker BF, Pfister HW (2002) Oxidative stress in bacterial meningitis in humans. Neurology 58:186–191
Becker BF (1993) Towards the physiological function of uric acid. Free Radic Biol Med 14:615–631
Sevanian A, Davies KJ, Hochstein P (1991) Serum urate as an antioxidant for ascorbic acid. Am J Clin Nutr 54:1129S–1134S
Benzie IF (2000) Evolution of antioxidant defence mechanisms. Eur J Nutr 39:53–61
Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78:6858–6862
Kastenbauer S, Koedel U, Pfister H-W (1999) Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis. J Infect Dis 180:1164–1170
Aycicek A, Iscan A, Erel O, Akcali M, Selek S (2006) Total antioxidant/oxidant status in meningism and meningitis. Pediatr Neurol 35:382–386
Nakazato Y, Shimazu K, Tamura N, Shimazu T, Hamaguchi K (1998) Hypouricemia in patients with meningitis. Rinsho Shinkeigaku 38:336–338
Koedel U, Pfister HW (1999) Oxidative stress in bacterial meningitis. Brain Pathol 9:57–67
Hamed SA, Hamed EA (2009) Zakary MM (2009) Oxidative stress and S-100B protein in children with bacterial meningitis. BMC Neurol 9:51
Spitsin S, Hooper DC, Leist T, Streletz LJ, Mikheeva T, Koprowski H (2001) Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease. Mult Scler 7:313–319
Scott GS, Hooper DC (2001) The role of uric acid in protection against peroxynitrite mediated pathology. Med Hypotheses 56:95–100
Acknowledgments
The study was supported by National Science Foundation (No. 81271327) and Technology Project of Guangdong Province (No. 2011B031800015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving the patient included the case report were in accordance with the ethical standards of the institutional board and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Liu, J., Li, M., Wang, X. et al. Serum uric acid levels in patients with infections of central nervous system. Acta Neurol Belg 116, 303–308 (2016). https://doi.org/10.1007/s13760-015-0571-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-015-0571-4